Genital manifestations of chronic GVHD (cGVHD) are generally thought to be limited to female patients, and organ system assessment forms generated by NIH Chronic GVHD Consensus Group include only female genital tract findings. It is not clear whether male genital organ involvement is truly a rare phenomenon in cGVHD, or is simply under-recognized. We report here glans penis involvement in a 41-year-old man, which was discovered when he presented with flare of his cutaneous and oral cGVHD.
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The patient is a 41-year-old man who underwent 8/8 HLAmatched related allogeneic PBSC transplantation from his brother for his multiply relapsed acute promyelocytic leukemia (APL). The conditioning regimen consisted of fludarabine and melphalan, and GVHD prophylaxis included tacrolimus and low-dose MTX. His post transplant course was significant for acute GVHD of the skin, followed by quiescent onset of lichenoid cGVHD involving mainly his skin, liver and oral cavity. He had multiple flares of cGVHD and responded each time to systemic and topical immunosuppression with various doses and schedules of tacrolimus, methylprednisolone and mycophenolic acid. Severe oral lesions involving his upper and lower lips, bilateral buccal mucosa and tongue were the most difficult to treat. He also developed a herpes zoster infection on his right frontal scalp, complicated by severe chronic post-herpetic neuralgia.
He had an isolated right parietal relapse of APL 2.5 years after transplantation, and was treated with whole brain radiation followed by intrathecal and systemic chemotherapies. His disease has remained in third CR. However, the patient later developed recurrent oral pain and lichenoid mucosal and skin lesions that were consistent with active cGVHD. He was started on moderatedose (0.5 mg/kg/day) corticosteroid. His oral and skin lesions progressed and required reinstitution of tacrolimus. He had persistent oral and skin lichenoid GVHD, but never developed sclerodermatous skin changes.
Most recently, the patient presented with complaints of severe tearing-like pain in the neck of his penis gland during sexual activity. He was taking oral acyclovir for herpes prophylaxis and fluconazole for fungal prophylaxis. His corticosteroid had been discontinued because of a recent bacteremia. On physical examination, he had open crusted bleeding lesions on his lips and lichenoid mucosal changes and ulcerations in his mouth (Figure 1a) , as well as raised papular clustering lesions with a shiny silver appearance on his palms and soles (Figure 1b) and dusky brown color lichenoid patches on his trunk and extremities. Genital examination revealed white lichenoid lesions on an erythematous base circumferentially involving the proximal part of his glans penis (corona glandis) and extending into retroglandular sulcus (Figure 1c) . The oral and genital lesions were almost identical in color and appearance. His laboratory studies showed elevated liver enzymes (aspartate aminotransferase 93 units/L, alanine aminotranferease 124 units/L, alkaline phosphatase 529 units/L and bilirubin 1.2 mg/dL) suggesting liver involvement by cGVHD as well. Cultures, obtained from glans penis lesion, did not grow herpes viruses or other microorganisms.
Methylprednisolone and tacrolimus were reinitiated at therapeutic doses, and all of his oral (Figure 2a ), cutaneous and penile lesions and contracture secondary to Peyronie's disease. 7 Underreporting of this manifestation of cGVHD may be in part due to lack of awareness and consequently underdiagnosis.
All skin can be involved with GVHD. However, the penile skin was intact in our case and the lesions were only confined to the glans penis, corona and retroglandular sulcus. It is important to both ask and look for genital lesions in patients with active cGVHD. Symptoms related to the genital tract should be reviewed with both female and male patients, and genital inspection should be included in the assessment of disease extent. More thorough evaluation should be considered in patients with suggestive symptoms. Infectious etiology of lesions should be ruled out by appropriate cultures and molecular studies.
The histopathology of cGVHD can be similar in patients with lichen planus and lichen sclerosus. 5, 8 It should also be noted that chronic persistent lesions in the genital tract may be a predisposition for other pre-malignant or malignant lesions. 8 A biopsy was not performed in our patient because he had an established diagnosis of cGVHD involving his skin and mouth. Moreover, he was being treated with acyclovir and fluconazole prophylaxis, and viral and fungal cultures were sterile, and his lesions clearly responded to systemic immunosuppressive therapy.
In summary, glans penis can be a site of involvement by cGVHD, adversely affecting sexual function in male patients due to severe pain. Routine assessment of male, as well as female, genitalia as part of the history and the physical examination is essential to better recognizing this rare treatable manifestation of cGVHD. 
